David Nyberg
Hematology & Oncology · Key West, FLNPI 1609884022
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,404 and has fallen 92.9% since, to $99 in 2021. That places this record below the midpoint for hematology & oncology clinicians in FL, where the typical reported total is $3,884.
Across 148 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$333
- Merck$303
- AstraZeneca$224
- Eisai Inc.$220
- Novartis$205
- Incyte Corporation$169
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,68795%
- Education$1375%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 12 | $333 |
| Merck | 19 | $303 |
| AstraZeneca | 8 | $224 |
| Eisai Inc. | 7 | $220 |
| Novartis | 12 | $205 |
| Incyte Corporation | 6 | $169 |
| Amgen | 8 | $123 |
| Johnson & Johnson(2 entities) | 9 | $120 |
| Bayer | 7 | $118 |
| Rigel Pharmaceuticals, Inc. | 2 | $118 |
| Pfizer | 7 | $111 |
| Clovis Oncology, Inc. | 7 | $109 |
| Foundation Medicine, Inc. | 5 | $78 |
| Lilly USA, LLC | 5 | $75 |
| Seagen Inc. | 5 | $68 |
| Bristol Myers Squibb | 4 | $59 |
| Genentech USA, Inc. | 4 | $55 |
| Exelixis Inc. | 3 | $53 |
| Array Biopharma Inc | 3 | $45 |
| Partner Therapeutics, Inc. | 3 | $44 |
| Astellas Pharma US Inc | 2 | $36 |
| Janssen Scientific Affairs, LLC | 2 | $34 |
| AbbVie | 2 | $28 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Verastem, Inc. | 1 | $20 |
| GSK | 1 | $18 |
| Novocure Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Eagle Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,825 in reported general payments places this provider in the 45th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in Key West
- Martin DietrichRockledge$6.2M
- Mark SocinskiOrlando$2.4M
- Tarek MekhailOrlando$2.2M
- Edgardo SantosFort Lauderdale$2M
- Daniel LandauOrlando$1.8M
- Wassim McHaylehAltamonte Springs$1.5M
- Edith PerezJacksonville$1.1M
- Steven FeinMiami$1M
- Vamsidhar VelchetiJacksonville$966K
- Shahram MoriOrlando$952K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.